For the quarter ended June 2025, VAREX IMAGING (VREX) reported revenue of $203 million, down 2.9% over the same period last year. EPS came in at $0.18, compared to $0.14 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $190.2 million, representing a surprise of +6.73%. The company delivered an EPS surprise of +350%, with the consensus EPS estimate being $0.04.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how VAREX IMAGING performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Industrial: $60.9 million versus $57.09 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.7% change.
- Revenues- Medical: $142.1 million compared to the $133.17 million average estimate based on two analysts. The reported number represents a change of -4.4% year over year.
- Gross profit- Industrial: $20.8 million versus the two-analyst average estimate of $18.11 million.
- Gross profit- Medical: $46.7 million versus $42.27 million estimated by two analysts on average.
View all Key Company Metrics for VAREX IMAGING here>>>
Shares of VAREX IMAGING have returned -16.5% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
VAREX IMAGING (VREX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
